الفهرس 
Impact of Occult Hepatitis B Infection in Patients with De novo HCV-Related Hepatocellular Carcinoma after Treatment with Direct Acting Antivirais
AbstractOnly 14 pages are availabe for public view
 |  | from | 119 |  |  |
| | | from | 119 | | |
Abstract
Introduction: Hepatocellular carcinoma is a worldwide health problem. DAAs are recently the standard care of chronic hepatitis C infection. Many recent studies showed surprising rates of de novo and recurrent HCC after DAAs treatment whether SVR was achieved or not. Occult hepatitis B virus infection (OBI) frequently occurs in HCC patients associated with chronic
hepatitis C (CHC) infection. This study aims to determine the prevalence and
impact of OBI on tumor characteristics and HCC treatment outcome regarding
recurrence and survival in patients with de novo HCV-related HCC after
treatment with DAAs.